Concurrence of Diabetic Ketoacidosis and Acute Ischemic Stroke due to Moyamoya Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Although the etiology of moyamoya disease (MMD) remains unknown, autoimmunity is one of the proposed pathogeneses. Unlike other autoimmune disorders that are associated with cerebral arteritis, concurrence of MMD and diabetes mellitus (DM) is rare. However, we encountered a patient with concurrent diabetic ketoacidosis (DKA) and acute ischemic stroke due to MMD. Our patient was diagnosed with glutamic acid decarboxylase antibody-positive type 2 DM (T2DM) based on laboratory and physical examination findings. Brain magnetic resonance images revealed an acute ischemic stroke in the left cerebral hemisphere and bilateral diffuse stenosis/occlusion in the middle cerebral artery and multiple collaterals. Thus, here, we report a patient with both T2DM and MMD who developed an acute ischemic stroke that was complicated by DKA.
Abstract
Although the etiology of moyamoya disease (MMD) remains unknown, autoimmunity is one of the proposed pathogeneses. Unlike other autoimmune disorders that are associated with cerebral arteritis, concurrence of MMD and diabetes mellitus (DM) is rare. However, we encountered a patient with concurrent diabetic ketoacidosis (DKA) and acute ischemic stroke due to MMD. Our patient was diagnosed with glutamic acid decarboxylase antibody-positive type 2 DM (T2DM) based on laboratory and physical examination findings. Brain magnetic resonance images revealed an acute ischemic stroke in the left cerebral hemisphere and bilateral diffuse stenosis/occlusion in the middle cerebral artery and multiple collaterals. Thus, here, we report a patient with both T2DM and MMD who developed an acute ischemic stroke that was complicated by DKA.
참고문헌 (13)
- Chen JB, "Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population", J Neurol Sci, 351(1-2), pp.184~186 (2015)[DOI]
- Bower RS, "Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease", Stroke, 44, pp.1997~1999 (2013)[DOI]
- 이란, "A Case of Moyamoya Disease in a Girl with Thyrotoxicosis", Yonsei Medical Journal, 50(4), pp.594~598 (2009), 연세대학교의과대학
- Kamasaki H, "A case of graves' disease diagnosed in the course of bilateral carotid artery stenoses (moyamoya disease); a case report and review of the literature", Clin Pediatr Endocrinol, 22, pp.39~44 (2013)[DOI]
- Watanabe C, "Chorea and broca aphasia induced by diabetic ketoacidosis in a type 1 diabetic patient diagnosed as moyamoya disease", Diabetes Res Clin Pract, 67, pp.180~185 (2005)[DOI]
- Suzuki S, "Moyamoya disease complicated by graves' disease and type 2 diabetes mellitus: report of two cases", Clin Neurol Neurosurg, 113, pp.325~329 (2011)[DOI]
- Noh BH, "Simultaneous occurrence of diabetic ketoacidosis, thyroid storm, and multiple cerebral infarctions due to moyamoya disease", J Pediatr Endocrinol Metab, 29, pp.221~225 (2016)
- Krebs A, "Adult-like but regressive increase of intima-media thickness and roughness in a child with type 1 diabetes", Pediatr Diabetes, 6, pp.161~164 (2005)[DOI]
- American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes care, 30(1), pp.S42~S47 (2007)[DOI]
- Liu LL, "Type 1 and type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for Diabetes in Youth Study", Diabetes Care, 32(Suppl 2), pp.S133~S140 (2009)[DOI]
- Kobayashi T, "Time course of islet cell antibodies and beta-cell function in non-insulindependent stage of type I diabetes", Diabetes, 36, pp.510~517 (1987)[DOI]
- Writing Group for the SEARCH for Diabetes in Youth Study Group, "Incidence of diabetes in youth in the United States", JAMA, 297, pp.2716~2724 (2007)[DOI]
- Klingensmith GJ, "The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study", Diabetes Care, 33, pp.1970~1975 (2010)[DOI]